Article
DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities
24 Nov 2022
Abstract excerpt
Resistance to chemo- and radiotherapy is a common event among cancer patients and a reason why new cancer therapies and therapeutic strategies need to be in continuous investigation and development. DNA damage response (DDR) comprises several pathways that eliminate DNA damage to maintain genomic stability and integrity, but different types of cancers are associated with DDR machinery defects. Many improvements...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
